CB1R appears to be primarily expressed on glioma cells, in contrast to CB2R, as indicated by its colocalization with the astrocytic marker glial fibrillary acidic protein (GFAP) (Wu et al., 2012; Hashemi et al., 2020). This evidence concerns the gene CNR1 and central nervous system cancer.